Taken together, these results suggested that a protein network including AURKA, RAD54L, CDC45, and ESPL1 proteins, key molecules of pathways deregulated in cancer, could represent a common regulatory signature to all BC subtypes. This evidence concerns the gene RAD54L and cancer.